Top compounds associated with response to SPRYD3

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.09	0.007
mRNA	alisertib	CTRPv2	pan-cancer	AAC	-0.086	0.007
mRNA	BCL-LZH-4	CTRPv2	pan-cancer	AAC	0.15	0.008
mRNA	narciclasine	CTRPv2	pan-cancer	AAC	-0.091	0.008
mRNA	MK 1775	CTRPv2	pan-cancer	AAC	-0.092	0.008
mRNA	KPT185	CTRPv2	pan-cancer	AAC	-0.1	0.008
mRNA	AKT inhibitor VIII	GDSC1000	pan-cancer	AAC	0.091	0.008
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.096	0.009
mRNA	BRD-K28456706	CTRPv2	pan-cancer	AAC	-0.097	0.01
mRNA	FH535	GDSC1000	pan-cancer	AAC	0.089	0.01

Download CSV